Variant Perception
Where We Disagree With the Market
The single sharpest disagreement is this: three published sell-side targets (Kotak ₹190, Jefferies ₹225, BofA ₹235) anchor a "Buy with ~23% upside" consensus that capitalises a wealth + AMC + MTF franchise at full probability — but the report's evidence is that the moat ends at the discount broker. The 55x trailing multiple is paying for three call options at once (wealth distribution, asset management, on-balance-sheet lending) where the gap to listed peers is 4x to 60x, the cleanest broker quarter (Q4 FY26, +88% YoY) is partly a base-shock comp off the Oct-2024 SEBI F&O cycle, and the bull/bear cash-conversion argument is fought on the wrong line of the cash-flow statement. We are not contrarian on the broker — the +17,917 net NSE active-client add in FY26 into a 7.1%-shrinking industry is the strongest single fact in the file and resists rebuttal. We are contrarian on what consensus has bolted on top of it: three premium call options assigned ~100% vesting, against evidence that at most one can plausibly clear inside 18 months. Q1 FY27 (early-August 2026) and the Aug 10 mini-lock-up expiry resolve the most price-sensitive part of the debate inside a single calendar week.
1. Variant Perception Scorecard
Variant Strength (0-100)
Consensus Clarity (0-100)
Evidence Strength (0-100)
Months to Primary Resolution
The score reflects four facts. Consensus is unusually clear — three Buys, a median ₹225 target, a Q4 beat that drew a same-day Jefferies raise. Evidence is high quality because the disagreement does not depend on out-of-sample forecasts; it leans on disclosed peer gaps (Angel One MTF ₹5,450 Cr vs Groww ₹1,036 Cr; Anand Rathi AuA ₹93,037 Cr vs Groww wealth stack ~₹25,000 Cr), a published forensic walk (FY25 pre-WC CFO 1.36x PAT vs reported CFO -₹962 Cr), and a confirmed regulatory base-shock (industry F&O ADTO -38% inside 12 months of the Oct-2024 framework). The primary resolution window is tight (Q1 FY27 print, early August) so the score is held down on materiality, not on edge — a 65 says "this is decision-relevant and testable in one quarter," not "we know we are right."
2. Consensus Map
Two assumptions are doing most of the work in the market price: that Q4 FY26 is a clean inflection (not a base-shock comp) and that 55x prices three asset-gatherer call options against a discount-broker P&L. Both are testable.
3. The Disagreement Ledger
Disagreement 1 — Q4 acceleration vs base-shock. Consensus took the Q4 FY26 print (+88% YoY revenue, +122% PAT, OPM 62%) and used it to validate a 35% EPS CAGR through FY28E, with Jefferies raising its target ₹210 → ₹225 within 24 hours. The variant view is that Q4 FY26's YoY comp lands on top of a quarter (Q4 FY25 ₹801 Cr revenue, OPM 48%) that was already inside the Oct-2024 SEBI F&O trough — the package took 38% out of industry F&O ADTO in 12 months, and Groww's own Q1 FY26 revenue fell 9.6% YoY against a less-suppressed base. Strip the base distortion: the cleaner full-year rate is +14%, the sequential margin walk (48% → 62%) is real operating leverage but on a fixed-cost base earning back, not a new ceiling. If we are right, the forward multiple is ~50x not ~40x and Q1 FY27 — the first quarter without the Oct-2024 comp — prints PAT YoY below 30% rather than the implied 60%+.
Disagreement 2 — Moat extension vs broker moat. This is the most material disagreement. Consensus is paying a 55x multiple where the broker P&L alone supports closer to 35x (Angel One 30x, Motilal 27x, Nuvama 27x on cleaner cash conversion). The premium is the wealth + AMC + MTF call options. The report's moat tab is explicit: Groww has a real, tested moat in the core broker — sole top-five player to add NSE actives (+17,917) in a 7.1%-shrinking industry, 24-32pp OPM gap vs Angel One — and the moat does not extend into the three premium segments. The peer gap is 4x to 60x in scale. The Anand Rathi comparison (74x P/E, 47% ROE, 59% ROCE) is the cleanest analogue for what consensus is paying for, but Anand Rathi has a multi-decade mass-affluent wealth franchise; Groww is mid-build on three franchises at once. If we are right, fair value compresses to the broker-only multiple plus a partial-vesting premium for the most plausible call option (AMC + State Street) — closer to ~₹140-170 than the consensus ₹225.
Disagreement 3 — Wrong cash-flow line. Both bull and bear sides argue about reported CFO. Bull says transitional, bear says structural. Both miss that the forensic walk reconciles cleanly: FY25 pre-WC CFO was 1.36x PAT, and the negative reported CFO is one-time tax catch-up (₹19,054 mn against the US outbound-merger provision) plus voluntary balance-sheet build into the NBFC and exchange-earmarked client float. The signal worth tracking is not "when does CFO turn positive" — it is whether the 100%-equity-funded MTF book earns above cost of equity. If the new MTF/Consumer-Credit lending returns less than 25% ROE, headline ROE compresses without any CFO movement and the multiple compresses with it. Consensus is staring at the wrong cell on the cash-flow statement and missing the real capital-efficiency question.
Disagreement 4 — Supply absorption is improving, not deteriorating. This is the only bullish variant on the page. Consensus treats every remaining VC stake (~37%) as a queued shock and dates the next forcing event as the Aug 10 mini-lock-up. The absorption record points the other way: Dec-10 2025 tranche cleared at -4%, May-12 2026 block (5% equity, ₹5,637 Cr) cleared at a 6% discount with founders unchanged. Each cleared block widens the depth of the absorbing book and compresses the discount-to-clear. If Aug 10 either passes with no second block, or sees a block at a tighter discount than 6%, the overhang narrative ends and the consensus "fundamentals fine, supply pressuring price" framing flips into "fundamentals fine, supply cleared." This is the disagreement that resolves first, against the smallest population of conditions.
4. Evidence That Changes the Odds
The strongest single item in the ledger is row 5 — the +17,917 net NSE active-client add. It supports the broker moat and refutes a "no edge anywhere" reading at the same time. We are not bearish on the broker; we are bearish on what consensus has layered on top.
5. How This Gets Resolved
The two highest-impact signals land inside the same 5-day August 2026 window: Q1 FY27 print (PAT YoY and AARPU) and the Aug 10 mini-lock-up expiry. A clean print into no second block resolves three of our four disagreements toward consensus simultaneously. A soft print into a second block at a wider discount resolves all four toward the variant. There is no other catalyst pair this concentrated inside the next six months.
6. What Would Make Us Wrong
The variant view rests on four claims, each disconfirmable. We can be wrong cleanly on any of them. The most likely failure mode is on Disagreement 1: if the Q1 FY27 print is a clean +60% YoY PAT with AARPU stabilising and F&O share holding near 10%, then the Q4 acceleration was operating leverage rather than a base-shock comp, the trailing 55x compresses to a defensible ~40x forward, and the sell-side targets become reachable. We are not making a structural call against the broker; we are making a probabilistic call on whether one good quarter is the new run-rate or the front-edge of a base recovery. One more quarter resolves it.
We can also be wrong on Disagreement 2 — the moat extension — if Fisdom integrates faster than guided and AMC AUM compounds inside a 12-month window. The State Street partnership is not a financial event; it is a credibility event, and if Groww AMC crosses ₹50,000 Cr by FY28 with TER realisation above 40bps, our 4x-to-60x peer-gap framing was too static. We have to accept that mass-affluent D2C economics may be structurally different — smaller AuA at higher TER yield could be worth more per rupee than the AuA gap implies. We do not currently see the evidence for that, but the evidence could arrive in two quarters of disclosure.
On Disagreement 3 — the CFO debate — we are wrong if the new MTF/Consumer-Credit book earns above 25% ROE inside FY28 and the headline 28.8% ROE persists without compression. This would mean the 100%-equity-funding strategy was correctly judged by management and our focus on capital efficiency is over-cautious. Conversely, if it earns sub-25%, the headline ROE compresses without any CFO movement and consensus has been arguing about the wrong line of the statement for two more years.
On Disagreement 4 — supply absorption — we are wrong the moment any founder participates in a secondary block. That single fact invalidates the absorption-capacity-improving thesis and reverts to the consensus overhang framing. The May 12 founder hold is the load-bearing fact for this disagreement; if it breaks, this disagreement breaks with it.
The first thing to watch is the Q1 FY27 print on August 10 (estimated), simultaneous with the mini-lock-up expiry — that single Tuesday resolves more of the variant debate than any other date in the calendar.
The variant view is more cautious than the published Buy consensus and more nuanced than the report's own bear case. We are not contrarian on the broker — the FY26 active-client add is the single fact in the file most resistant to rebuttal — but consensus has bolted three premium call options onto the broker P&L, and the evidence supports at most one inside 18 months. The 55x is paid for a franchise that does not yet exist at peer scale.